A Study of the Effects of Itraconazole on the Plasma Levels of Nemtabrutinib (MK-1026-013)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

January 6, 2024

Study Completion Date

January 6, 2024

Conditions

Healthy

Interventions

DRUG

Nemtabrutinib

Oral administration

DRUG

Itraconazole

Oral administration

Trial Locations (1)

Labcorp Clinical Research Unit Inc. (Site 0001), Honolulu

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06688045 - A Study of the Effects of Itraconazole on the Plasma Levels of Nemtabrutinib (MK-1026-013) | Biotech Hunter | Biotech Hunter